RemedyRepack Inc. is recalling 4,486 tablets of Ranitidine (150 mg), a medication commonly used to treat and prevent heartburn and stomach ulcers. This recall was issued after the supplier notified the company that the tablets may contain N-Nitrosodimethylamine (NDMA) at levels higher than what is considered safe. Approximately 4,486 tablets were affected and distributed to medical facilities in California and New York. If you are taking this medication, you should consult with a healthcare professional or pharmacist to find an alternative treatment and return any unused portions of the affected drug for a refund.
NDMA is classified as a probable human carcinogen, meaning it is a substance that could increase the risk of cancer following long-term exposure to levels above acceptable limits.
Return for refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.